Pregled bibliografske jedinice broj: 665280
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma // British journal of haematology, 157 (2012), 3; 401-403 doi:10.1111/j.1365-2141.2011.08998.x (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 665280 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The addition of rituximab reduces the incidence of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma
Autori
Mitrović, Zdravko ; Bast, Martin ; Bierman, Philip J. ; Bociek, Robert G. ; Vose, Julie M. ; Chan, Wing C. ; Armitage, James O.
Izvornik
British journal of haematology (0007-1048) 157
(2012), 3;
401-403
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
antibodies monoclonal murine derived; antineoplastic combined chemotherapy protocols; central nervous system neoplasms; lymphoma large B-cell diffuse
Sažetak
This is a retrospective analysis of the frequency of CNS relapses in DLBCL patients treated prior to and during the rituximab era. The addition of rituximab to chemotherapy significantly decreases the frequency of CNS relapses.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1081872-1908 - Dijagnostika i liječenje limfoma (Aurer, Igor, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Profili:
Zdravko Mitrović
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
